Enterprise Account Manager - Point of Care Diagnostics - TN/NC/SC/GA/F…
AbbottFull Time
Senior (5 to 8 years), Expert & Leadership (9+ years)
Candidates should possess deep domain knowledge of the Diagnostic Services industry and preferred molecular diagnostic experience, with a strong background in selling oncology-based tests and services into the Pathology and/or Oncology clinical communities. They require experience in complex selling environments, demonstrated success in recruiting and retaining talent, and the ability to prioritize and align organizational goals. Furthermore, the ideal candidate should be able to develop and utilize cross-functional relationships, provide an integrated MolDx/SaaS solution, and engage in a consultative selling process.
The Area Vice President, South will be responsible for managing business results, sales activities, driving strategic collaborations, and cross-functional initiatives for their team, including making day-to-day decisions regarding resource deployment, cost allocation, and business direction. They will achieve area-level sales objectives, develop and execute area and regional business plans, directly execute sales strategies and tactics, develop and maintain key customer relationships, plan and conduct area sales meetings, evaluate the performance of Regional Sales Managers and Clinical Account Executives, identify contracting opportunities, maintain a high level of product and market knowledge, and support internal department sales-facing initiatives. Additionally, the AVP will execute on area-level hiring plans, collaborate with cross-functional partners, and drive sales enablement through CRM and data analytics platforms, while also providing field support and attending executive-level meetings.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.